MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2023

Type / Class
Equity / Common Stock, $0.00000002 par value
Symbol
MEIP on Nasdaq
Shares outstanding
29,545,622
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 3.7% 1,093,188 Anson Funds Management LP 22 Jul 2025

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$958,000 0
2023 Q2 145,654 $958,000 -$28,712,302 $6.58 1
2023 Q1 48,845,759 $11,179,346 -$295,320 $0.23 45
2022 Q4 49,485,704 $12,052,989 -$1,007,880 $0.24 45
2022 Q3 47,607,776 $18,402,998 -$90,868 $0.39 55
2022 Q2 47,449,879 $28,704,093 -$5,095,402 $0.60 59
2022 Q1 56,055,550 $33,769,440 -$85,348,603 $0.60 85
2021 Q4 89,185,933 $238,011,275 +$60,987,652 $2.67 104
2021 Q3 65,176,813 $179,904,137 -$10,864,219 $2.76 100
2021 Q2 68,991,345 $196,726,475 -$5,446,204 $2.85 105
2021 Q1 70,784,540 $242,767,740 +$18,669,651 $3.43 105
2020 Q4 65,458,547 $172,902,331 -$2,754,748 $2.64 106
2020 Q3 66,088,757 $206,202,307 +$7,178,715 $3.12 100
2020 Q2 62,875,358 $259,680,491 +$1,477,050 $4.13 100
2020 Q1 64,570,596 $103,561,509 +$22,397,311 $1.61 77
2019 Q4 49,354,861 $122,400,810 +$24,179,217 $2.48 76
2019 Q3 36,909,319 $62,006,463 -$21,615,455 $1.68 69
2019 Q2 45,960,278 $114,897,440 +$11,724,666 $2.50 70
2019 Q1 41,010,769 $125,904,000 +$2,372,403 $3.07 62
2018 Q4 40,029,928 $105,434,000 +$7,721,183 $2.64 55
2018 Q3 36,164,953 $155,872,000 -$1,323,234 $4.31 59
2018 Q2 36,391,138 $143,378,000 +$111,542,358 $3.94 57
2018 Q1 8,504,579 $17,606,115 -$506,425 $2.07 42
2017 Q4 8,747,898 $18,344,388 -$186,571 $2.10 47
2017 Q3 8,638,250 $23,161,366 +$5,784,349 $2.68 53
2017 Q2 6,647,146 $15,883,000 +$1,199,231 $2.39 44
2017 Q1 6,302,427 $10,208,000 +$579,181 $1.62 42
2016 Q4 6,477,857 $9,326,000 +$440,611 $1.44 33
2016 Q3 5,522,709 $9,719,000 -$2,415,654 $1.76 36
2016 Q2 7,628,992 $10,371,000 -$3,091,435 $1.36 33
2016 Q1 9,938,127 $12,522,000 +$584,155 $1.26 36
2015 Q4 6,600,579 $10,561,000 +$592,477 $1.60 37
2015 Q3 6,217,539 $9,759,657 +$1,986,306 $1.57 33
2015 Q2 4,929,037 $8,428,000 -$5,402,971 $1.71 37
2015 Q1 7,979,253 $14,284,000 -$53,086,251 $1.79 41
2014 Q4 22,695,018 $96,926,463 +$35,679,904 $4.27 50
2014 Q3 12,032,981 $83,027,000 -$3,244,730 $6.90 33
2014 Q2 13,292,012 $84,269,801 -$19,517,998 $6.34 40
2014 Q1 13,970,941 $155,500,299 +$18,575,595 $11.13 48